Effective October 13, 2022, the Esbriet Co-pay Program has new processing information for pharmacy adjudicated claims. Patients will use their existing member ID with the following new details:
Esbriet BIN: 600426, PCN: 54, Group Number: EC38523002
For more information, please call the Help Desk at (877) 780-4958.
The information contained in this section of the site is intended for US specialty pharmacy representatives only. Click "OK" if you are a specialty pharmacy representative.
With the Esbriet Co-pay Program:
*Commercial insurance includes plans you receive from your job or plans from the Health Insurance Marketplace. Government programs like Medicare and Medicaid are not commercial insurance.
If you are not eligible for the Esbriet Co-pay Program, there may be other options for co-pay assistance. Call (877) 780-4958 or visit EsbrietCopay.com to learn more.
Esbriet is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF).
It is not known if Esbriet is safe and effective in children.
Before you take Esbriet, tell your doctor if you:
Esbriet may cause serious side effects, including:
Your doctor may change your dose or discontinue Esbriet if side effects do not go away.
The most common side effects of Esbriet include upper respiratory tract infections, feeling tired, headache, dizziness, loss of appetite, sinusitis, insomnia, or weight loss.
These are not all the possible side effects of Esbriet.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch or to Genentech at 1-888-835-2555.
Please see full Prescribing Information, including Patient Information, for additional important safety information.